Loading...
Abbott Laboratories
ABT•NYSE
HealthcareMedical - Devices
$133.55
$-0.39(-0.29%)
Abbott Laboratories (ABT) Financial Performance & Statements
Review Abbott Laboratories’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.59%
↑ 4.59%
Operating Income Growth
5.36%
↑ 5.36%
Net Income Growth
134.18%
↑ 134.18%
Operating Cash Flow Growth
17.86%
↑ 17.86%
Operating Margin
16.97%
↑ 16.97%
Gross Margin
55.89%
↑ 55.89%
Net Profit Margin
31.89%
↑ 31.89%
ROE
30.76%
↑ 30.76%
ROIC
10.50%
↑ 10.50%
Abbott Laboratories (ABT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Abbott Laboratories stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.97B | $10.63B | $10.38B | $9.96B |
| Cost of Revenue | $4.94B | $4.70B | $4.57B | $4.42B |
| Gross Profit | $6.03B | $5.94B | $5.81B | $5.54B |
| Gross Profit Ratio | $0.55 | $0.56 | $0.56 | $0.56 |
| R&D Expenses | $749.00M | $713.00M | $698.00M | $679.00M |
| SG&A Expenses | $2.91B | $2.90B | $2.92B | $2.94B |
| Operating Expenses | $4.12B | $4.08B | $4.08B | $4.09B |
| Total Costs & Expenses | $9.06B | $8.78B | $8.65B | $8.51B |
| Interest Income | $91.00M | $91.00M | $82.00M | $80.00M |
| Interest Expense | $136.00M | $142.00M | $58.00M | $61.00M |
| Depreciation & Amortization | $807.00M | $801.00M | $805.00M | $805.00M |
| EBITDA | $2.99B | $2.91B | $2.64B | $2.34B |
| EBITDA Ratio | $0.27 | $0.27 | $0.25 | $0.23 |
| Operating Income | $1.91B | $1.86B | $1.72B | $1.45B |
| Operating Income Ratio | $0.17 | $0.17 | $0.17 | $0.15 |
| Other Income/Expenses (Net) | $119.00M | $81.00M | -$62.00M | $50.00M |
| Income Before Tax | $2.03B | $1.94B | $1.61B | $1.44B |
| Income Before Tax Ratio | $0.18 | $0.18 | $0.15 | $0.14 |
| Income Tax Expense | -$7.20B | $294.00M | $305.00M | $211.00M |
| Net Income | $9.23B | $1.65B | $1.30B | $1.23B |
| Net Income Ratio | $0.84 | $0.15 | $0.13 | $0.12 |
| EPS | $5.33 | $0.95 | $0.75 | $0.71 |
| Diluted EPS | $5.27 | $0.94 | $0.74 | $0.70 |
| Weighted Avg Shares Outstanding | $1.73B | $1.73B | $1.73B | $1.73B |
| Weighted Avg Shares Outstanding (Diluted) | $1.75B | $1.75B | $1.75B | $1.75B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan